Key result
In cardiomyopathic hamsters, olmesartan improved abnormal intercalated disc ultrastructural changes, attenuated the decrease of beta-catenin expression, decreased VT/VF induction, and improved survival.
Why the study?
Does olmesartan improve intercalated disc remodelling and reduce arrhythmogenesis in UM-X7.1 cardiomyopathic hamsters?
Does olmesartan improve intercalated disc remodelling and reduce arrhythmogenesis in UM-X7.1 cardiomyopathic hamsters?
Angiotensin receptor blockade with olmesartan attenuates intercalated disc remodelling and reduces lethal ventricular arrhythmias in a hamster model of heart failure.
Answers are grounded in this paper and cite their sources.
Should not inform clinical ARB use in HF; leaves open whether ARBs attenuate intercalated disc remodelling in cardiomyopathy.
AIMS: The intercalated disc (ID) contains two complexes, the adhesion junction (AJ) and the gap junction (GJ). We studied ID remodelling and its potential role in arrhythmogenesis and investigated the effects of olmesartan on ID remodelling during development of heart failure (HF) in UM-X7.1 cardiomyopathic hamsters. METHODS AND RESULTS: The UM-X7.1 hamsters showed left ventricular (LV) hypertrophy by the age of 10-15 weeks and a moderate impairment in LV contractility at 20 weeks. At age 10-15 weeks, 10-20% of the hamsters died suddenly without HF, and ventricular tachycardia (VT)/ventricular fibrillation (VF) was induced in ∼30% of hamsters. Electron microscopy showed that density linking cell-to-cell adhesion was irregular and unclearly defined, and filamentous structures attached to electron-dense components were arranged in disorder. Western blotting showed that the total cellular expression level of β-catenin was decreased, and expression of nuclear β-catenin, which functions as a T-cell factor/lymphocyte enhancer binding factor transcriptional activator, was also remarkably decreased. At age 20 weeks, LV connexin43 expression showed a remarkable decrease, and the VT/VF induction rate was ∼90%. In UM-X7.1 hamsters, olmesartan improved abnormal ID ultrastructural changes, attenuated the decrease of total cellular and nuclear β-catenin expression, decreased VT/VF induction, and improved survival rate. CONCLUSION: These results suggest that changes in AJ protein precede connexin43 GJ alterations, and ID remodelling might contribute to arrhythmogenesis during the development of HF. Angiotensin receptor blockade might be a new therapy for lethal ventricular arrhythmia by modulating both AJ and GJ remodelling.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2011) studied Heart failure in cardiomyopathic hamsters. Olmesartan vs. Untreated hamsters was evaluated on Intercalated disc ultrastructural changes, beta-catenin expression, VT/VF induction, and survival rate. In cardiomyopathic hamsters, olmesartan improved abnormal intercalated disc ultrastructural changes, attenuated the decrease of beta-catenin expression, decreased VT/VF induction, and improved survival.
Synapse has enriched 10 related papers. Consider them for comparative context: